Enabla is a private company focused on developing software solutions for business operations.
This slot renders the company's funding history: dates, rounds, amounts, valuations and lead investors once populated in data/funding-rounds.json.
Alongside Lila Sciences, Enabla proves AI can systematically screen and design molecules against known targets in silico, replacing massive physical screens; early commercial validation of AI-native drug discovery.